Search
Drug Impact Events
| Date | Lead Company |
Event | Type | Approval Change |
Approval Likelihood |
|---|---|---|---|---|---|
| 6/26/17 | Clarus Therapeutics | Jatenzo for Hypogonadism | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/26/17 | Alnylam (ALNY) | Givosiran for Porphyria | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/26/17 | Neothetics (NEOT) | LIPO-202 for Fat Removal | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/26/17 | Seattle Genetics (SGEN) | Adcetris for Hodgkin's Lymphoma | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/26/17 | Sumitomo Dainippon Pharma (4506:JP) | Napabucasin for Gastric Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
| Expected Date Range |
Lead Company |
Drug | Expected Catalyst |
|---|---|---|---|
| 06/27/17 | Subscribers Only | Subscribers Only | Regulatory - Approval Decision (Europe) |
| 06/27/17 | Subscribers Only | Subscribers Only | Regulatory - Approval Decision (Europe) |
| 06/27/17 | Subscribers Only | Subscribers Only | Regulatory - Approval Decision (Europe) |
| 06/27/17 | Subscribers Only | Subscribers Only | Regulatory - Approval Decision (Europe) |
| 06/27/17 | Subscribers Only | Subscribers Only | Regulatory - Approval Decision (Europe) |
Special Reports
4.jpg "Beta Amyloid Antagonists/Inhibitors in Alzheimer’s Disease, Phase III")
1.jpg "Pipeline Biologics in Psoriasis, Phase III")
Latest Pharma Insights
BioMedTracker in the News
| Date | Headline |
|---|---|
| 06/16/17 | Market watch: Upcoming market catalysts in Q3 2017 |
| 03/17/17 | Market watch: Upcoming market catalysts in Q2 2017 |
| 12/29/16 | Market watch: Upcoming market catalysts in Q1 2017 |
| 09/29/16 | Market watch: Upcoming market catalysts in Q4 2016 |
| more... | |